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Abstract 
The validity and reliability of the EQ-5D-5L in comparison with the standard 3L has 
been tested through the analysis of psychometric properties making use of different samples of 
patients. However, it is likely that the condition of the illness may affect the power of the 5L 
version with respect to the 3L one. Here we report on parallel testing of EQ-5D-5L and 3L 
administered to a sample of chronic patients of both somatic and mental illness. The aim of this 
study is to check some psychometric properties in both subsamples. 
Methods: We check for the usual psychometric properties: feasibility, (in)consistency, 
ordinality (and transitivity), informativity, face validity and convergent validity. Also, we 
perform new analysis for checking transitivity and the Cronbach-α for convergent validity. 
Finally, we proposed a complementary way for looking at the property of informativity through 
three different indexes (effective, absolute and overall) based on the statistical discriminatory 
power.  
Data: We have a total of 1002 questionnaires finally collected. 444 (46.25%) chronic 
mental patients, 516 (53.75%) have somatic chronic illnesses; 42 observations of unknown 
origin of the illness have been dropped to perform this analysis.  
Results: The mean value reported in the VAS for the full sample is 60.93. Somatic 
patients report a mean of 64.42 points in this scale and mental patients report 56.83 points in the 
VAS. Analyzing the distribution of the responses to problems on each dimension we found, for 
all cases, a highly skewed distribution. Moreover, the distribution of responses changes 
significantly between subsamples, as expected. 
In all dimensions, it seems that somatic patients take more advantage of the extra levels 
introduced by the EQ-5D-5L. This group reduces to a greater extent the missing response rate, 
commit less (and of lower importance) inconsistencies, get a higher correlation of the 5L scale 
and the VAS within the 3L levels, complements better the dimensions to get an overall score 
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(measured through the Cronbach’s alpha), reduces in a more significant way the “no problem” 
response and the Informativity gain is also superior (for both the Shannon Evenness Index and 
our Absolute Index). This higher performance of the EQ-5D-5L on somatic patients is endorsed 
by a higher preference of somatic patients toward the 5L version of the questionnaire than to the 
3L one. 
Conclusion: Results show the suitability of the 5L version in both subsamples, but it is 
much more effective for somatic patients. These subsamples’ differences may be of concern 
when aggregating and comparing different data. 
 
1. Background 
The validity and reliability of the EQ-5D-5L in comparison with the EQ-5D-3L has 
been proven in prior researches through the analysis of psychometric properties making use of 
different samples of patients located on different countries (Pikard, A.S. et al., 2007; Kim, S.H. 
et al., 2012; Kim, T.H. et al., 2012; Scalone, L. et al., 2012; Janssen, M.F., 2012). 
However and despite the richness of the data collected up to now, the analysis has been 
carried out without considering possible iterations between the source of the illness and the 
impact of the two intermediate levels that the EQ-5D-5L incorporates with respect to its 
previous version of three levels.  
While certain socio-demographic variables have been reported as moderators or 
enhancers in previous studies (for example, gender is a relevant variable when looking possible 
ceiling effects (Kim, T.H. et al., 2012)), it is also very likely that the source of the illness of the 
patient affects the power of the 5L version with respect to the 3L one in different aspects.  
In order to examine this concern, we exploit a dataset composed by patients dealing 
with chronic diseases
1
. This specific sample will help the analysis in two ways. A first 
advantage of this sample in comparison with others is that it would reduce the number of 
individuals expected to report to be in health state 11111 and thus will generate a greater 
dynamism when passing from the 3L version to the 5L one. Also, focus our attention in chronic 
patients will help us to discern the source of the illness affecting the patient. 
Given our particular sample, the clearer and less problematic division among diseases is 
the one given by somatic and mental source of the illness. Being this classification feasible, the 
                                               
1
 Chronic Diseases: diseases which have one or more of the following characteristics: they are permanent, leave 
residual disability, are caused by non-reversible pathological alteration, require special training of the patient for 
rehabilitation, or may be expected to require a long period of supervision, observation, or care. Other terms used in 
the scientific literature are: chronic illness, chronic conditions. rehabilitation, or may be expected to require a long 
period of supervision, observation, or care. Other terms used in the scientific literature are: chronic illness, chronic 
conditions. 
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aim of this study is to check some psychometric properties in both subsamples and compare the 
results in order to check a potential different effect over both subsamples.  
The paper is organized as follows. First, in section 2, data and methods for the analysis 
of the psychometric properties studied are presented. Section 3 shows preliminary results. 
Section 4 opens to discussion together with the conclusions.  
 
2. Data and Methods 
2.1. The questionnaire 
In terms of the measurement instruments used in the study, patients answered a 
questionnaire, which contains the two versions, EQ-5D-5L and 3L, the EQ-VAS and a page of 
socio-demographic questions. 
The order of the questionnaire is the following: it starts with the EQ-5D-5L followed by 
socio-demographic questions, sex, age, education level, main activity, nationality and postal 
code, and if the individual is a smoker or not; then, the 3L, and the VAS. Finally, at the end of 
the questionnaire, we include two questions in which individuals are asked to value which of the 
two questionnaires they found easier to answer, and which of the two versions allowed them to 
better express their health status, respectively. 
2.2. Data Collection process 
Questionnaires were delivered by doctors at consultancy and filled by the patient. 
Doctors provided also extra information as the ICPC (International Classification of Primary 
Care) that helps to classify individuals in subgroups according to their diagnosed illness, and 
resolve the doubts patients may had when filling the questionnaires.  
Data were collected in several medical centers that can be classified into three different 
institutions: primary care centers, specialist clinics (mental health care center, rheumatology, 
pneumology) and a psychiatric day hospital. Doctors were responsible of delivering the 
questionnaire to patients following our instructions. For specialist consultations and the 
psychiatric day hospital, the questionnaire was administered to all patients attending the center 
in the period, while on the primary care centers a criterion of convenience was used by doctors: 
they provided the questionnaire where they were able given their time constraints. Thus, our 
sample contains all the population of chronic patients attending the specialist or the psychiatric 
day care hospital and a random sample of chronic patients attending primary care centers. 
The somatic and mental care groups are generated according to the institution patients 
attended and to its ICPC and ICD-10 (International Statistical Classification of Diseases and 
Related Health Problems, 10th Revision). In such a fashion, somatic group is composed by 326 
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patients from primary care and 190 from specialist consultancies while the mental group comes 
from primary care (3), specialist consultancies (284) and the psychiatric day care hospital (157). 
Data were collected in 2010 and 2011. 
2.3 Methods for data analysis 
In order to test the validity and reliability of the 5L descriptive system, we follow the 
line opened by Janssen et al. (2008) looking as the main psychometric properties: feasibility, 
(in)consistency, ordinality (and transitivity), informativity, face validity and convergent validity 
(Jansssen et al, 2008, 2012; Kim et al 2012; Scalone et al, 2012). In addition, we perform new 
analysis for checking transitivity and the Cronbach-α for convergent validity. Finally, we 
propose a complementary way for looking at the property of informativity through three 
different indexes (effective, absolute and overall) based on the statistical discriminatory power. 
Although we lack of dimension-specific VAS, the large-scale of the study as well as the 
convergent validity property allow us to use the EQ-VAS where needed.  
We also look at other relevant information, through regression analysis and covariates 
between variables, in order to explain some features of our dataset. 
 
3. Results 
3.1 Descriptive Analysis 
We have a total of 1002 questionnaires finally collected. Among the full sample, 444 
(46.25%) of the questionnaires correspond to chronic mental patients, 516 (53.75%) have 
somatic chronic illnesses, and for the remaining 42 the origin of the illness is unknown and 
therefore are dropped from the analysis.  
The mean age of the respondents in our sample is 55.93 years ranging from 15 to 94. By 
type of illness, we find that the population from the somatic group is statistically older 
(F(1,937)=555.42, p<.01) than the one from the mental one (66.75 vs 43.51).  
The percentage of women is slightly higher than men (51.42 vs 48.58). We also found 
that the groups are statistically unbalanced on this regard (F(1,950)=6.65, p<.05) being the 
proportion of male patients higher on the somatic group (52.44%) than on the mental one 
(47.55%). 
The majority of participants in this study are Spaniards, while there are a 9.8% of 
respondents who have a different nationality. Among those who are from a different country, we 
know that the mean of years they have lived in Spain is 13.25.  
A big part of the sample reports to have achieved just primary studies (454, the 48.4%)  
while it is much lower the percentage of patients  who have reached high school (277, the 
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29.53%). Only the 12.47% of the population has superior studies (university or similar). The 
9.59% has not received any kind of education. Looking by subsamples, mental patients tend to 
be more educated than somatic ones (table 1). 
The 28.63% (264) are employed and the 29.72% retired. The 16.16% of respondents are 
house-workers, and a 9.44% are unemployed. There is a non-negligible number of individuals 
disabled in the sample (124, the 13.23%). Only the 2.82% of the participants are students. As 
happened with education, the sample is highly unbalanced attending to the origin of the illness 
(table 1) being especially relevant the difference on retired and unemployed population. 
Table 1: Distribution of subsamples regarding studies and main activity 
  
Somatic Mental 
  
% Std. Err. % Std. Err. 
Stu
d
ies 
Uneducated * 11.59% 0.0142 7.23% 0.0125 
Primary ** 56.78% 0.0220 38.46% 0.0235 
High School ** 22.79% 0.0186 37.53% 0.0234 
Superior ** 8.84% 0.0126 16.78% 0.0181 
M
ain
 A
ctivity 
Employed ** 22.42% 0.0186 36.12% 0.0235 
Retired ** 44.64% 0.0222 11.72% 0.0158 
Disable ** 9.52% 0.0131 17.70% 0.0187 
House-Worker ** 21.03% 0.0182 10.29% 0.0149 
Student ** 0.40% 0.0028 5.74% 0.0114 
Unemployed ** 1.98% 0.0062 18.42% 0.0190 
 
* Difference significant at p<.05 
  
 
** Difference significant at p<.01 
  
  
The difference between the mean time respondents have symptoms of the illness and 
the mean time they were diagnosed is 1.67 years for the full sample. Interesting is the fact that 
mental patients used to be diagnosed later than somatic (2.59 vs 1.02 years) being this 
difference statistically significant (p<.01). Concerning the self-perception of severity of the 
illness we find that 205 (21.68%) perceive severity of illness as mild, 465 (50.44%) perceive it 
as moderate, and 257 (27.89%) as severe. For illness origin, the groups are quite balanced 
although somatic patients tend to claim more often that their disease has a moderate severity 
(p<.05). 
The mean value reported in the VAS for the full sample is 60.93. Somatic patients 
report in mean 64.42 points in this scale. Mental patients however, report in mean a lower value, 
56.83 points in the VAS. Moreover, this difference is highly significant (p<.01). 
Analyzing the distribution of the responses on each dimension (table 2) we found, for 
all cases, a much skewed distribution. In particular, and although we are considering only 
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chronic patients, lower levels (5L-1 and 5L-2) are systematically more often chosen than higher 
ones. 
Moreover, and as was expected, the distribution of responses change significantly 
between subsamples. The closest distribution between subsamples, takes place on the usual 
activities one, for which we cannot reject the equality of distribution at p<.05. 
Table 2: Distribution of responses for each dimension by subsample 
  
mo *** sc *** ua * pd *** ad *** 
Somatic 
1 38.4% 59.6% 45.8% 18.5% 37.0% 
2 29.1% 23.3% 29.7% 44.7% 37.8% 
3 23.8% 12.4% 16.1% 24.7% 19.1% 
4 7.9% 3.7% 5.6% 10.7% 4.9% 
5 0.8% 1.0% 2.7% 1.4% 1.2% 
Mental 
1 68.5% 76.1% 44.0% 38.8% 24.4% 
2 16.9% 14.4% 23.9% 27.8% 28.0% 
3 10.6% 6.3% 19.2% 19.4% 23.5% 
4 3.2% 2.7% 7.9% 10.8% 16.9% 
5 0.9% 0.5% 5.0% 3.2% 7.2% 
        * Difference between samples' distributions significant at p<.1 
        ** Difference between samples' distributions significant at p<.05 
        *** Difference between samples' distributions significant at p<.01 
 
3.2 Analysis of psychometric properties 
Feasibility: The overall effect of the 5L questionnaire in terms of response rate, is positive as 
long as all the measures are significantly (p<.01) different between the 3L and 5L 
questionnaires, supporting the fact that the 5L achieves a higher response rate. However, this 
effect is mainly driven by changes in somatic patients. Although the resulting measures from 
mental patients also support a higher response rate for 5L than for 3L, the changes are not 
significant or if so are not high. Moreover, we have also to notice that the responses rates found 
for this subsample of patients are very high for both 3L and 5L, so there is little room for 
improvement. 
Comparing between subsamples, we only find a significant (p<.05) higher proportion of 
missing responses in somatic patients for mobility and anxiety/depression when looking the 3L 
questionnaire. Interesting enough is the fact that this difference disappears on the 5L instrument. 
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Table 3: Feasibility 
  
5L 3L 
  
% Missing Std. Err. [95% Conf. Interval] % Missing Std. Err. [95% Conf. Interval] 
Fu
ll Sam
p
le 
Profile ** 0% 0 0% 0% 1.25% 0.00359 0.55% 1.95% 
Partial profiles ** 0.94% 0.00311 0.33% 1.55% 2.50% 0.00504 1.51% 3.49% 
mo ** 0% 0 0% 0% 1.67% 0.00413 0.86% 2.48% 
sc ** 0% 0.00104 0% 0% 1.46% 0.00387 0.70% 2.22% 
ua ** 0.21% 0.00147 -0.08% 0.50% 1.56% 0.004 0.78% 2.35% 
pd ** 0.31% 0.00180 -0.04% 0.67% 1.35% 0.00373 0.62% 2.09% 
ad ** 0.42% 0.00208 0.01% 0.82% 1.77% 0.00426 0.94% 2.61% 
So
m
atic 
Profile ** 0% 0 0% 0% 1.74% 0.00577 0.61% 2.88% 
Partial profiles * 1.36% 0.00510 0.36% 2.36% 3.49% 0.00809 1.90% 5.08% 
mo ** 0% 0.00000 0% 0% 2.52% 0.00691 1.16% 3.88% 
sc ** 0% 0.00194 0% 1% 1.94% 0.00607 0.74% 3.13% 
ua ** 0.19% 0.00194 -0.19% 0.57% 2.13% 0.00636 0.88% 3.38% 
pd * 0.39% 0.00274 -0.15% 0.93% 1.74% 0.00577 0.61% 2.88% 
ad ** 0.58% 0.00335 -0.08% 1.24% 2.52% 0.00691 1.16% 3.88% 
M
en
tal 
Profile 0% 0 0% 0% 0.68% 0.00389 -0.09% 1.44% 
Partial profiles * 0.45% 0.00318 -0.17% 1.08% 1.35% 0.00549 0.27% 2.43% 
Mo 0% 0 0% 0% 0.68% 0.00389 -0.09% 1.44% 
sc* 0% 0 0% 0% 0.90% 0.00449 0.02% 1.78% 
Ua 0.23% 0.00225 -0.22% 0.67% 0.90% 0.00449 0.02% 1.78% 
Pd 0.23% 0.00225 -0.22% 0.67% 0.90% 0.00449 0.02% 1.78% 
Ad 0.23% 0.00225 -0.22% 0.67% 0.90% 0.00449 0.02% 1.78% 
 Profile: The full profile is completely blank. Partial Profile: At least one dimension is blank. Includes also profiles completely blank 
 
* Difference between 3L and 5L significant at p<.05 
     
 
** Difference between 3L and 5L significant at p<.01 
     
 
Inconsistencies: There is a non-negligible percentage of the population, 14.77%, who 
committed inconsistencies when reporting the health states in the 5L and in the 3L 
questionnaires. This 14.77% is responsible for 177 inconsistent responses (3.8% of the total 
amount of pairs 3L-5L). Disaggregating the sample into somatic/mental patients it is found that 
mental patients are significantly (F(1,948)=3.92; p<.05) more prone to commit inconsistencies 
than somatic.  
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Table 4: Percentage of inconsistent patients found by groups 
  
N Proportion Std. Err. [95% Conf.Interval] 
Full 
Sample 
Consistent 
948 
85.23% 0.01153 82.97% 87.49% 
Inconsistent 14.77% 0.01153 12.51% 17.03% 
Somatic 
Consistent 
507 
87.38% 0.01476 84.48% 90.27% 
Inconsistent 12.62% 0.01476 9.73% 15.52% 
Mental 
Consistent 
441 
82.77% 0.01800 79.23% 86.30% 
Inconsistent 17.23% 0.01800 13.70% 20.77% 
 
Making use of the proposed weights for inconsistencies by Janssen et al. (figure 1) and 
examining each dimension separately (figure 2), we find that, excepting for the self-care 
dimension in which there are only inconsistencies of weight one, mental patients commit in 
average higher inconsistencies. Despite this, the differences somatic/mental on this regard are 
only statistically significant (p<.05) for mobility and usual activities. 
In addition, we can compute the specific patient j’s average inconsistency weight (AIW) 
as the sum of all the weights of the inconsistencies committed by patient “j”, divided by the 
amount of inconsistencies done by this patient. Between those who committed at least one 
inconsistency, the AIW are 1.46, 1.22 and 1.66 for the full sample, somatic subsample and 
mental subsample respectively. Moreover, the difference between somatic and mental patients is 
highly significant (p<.01) reinforcing not only the idea that mental patients do commit more 
inconsistencies, but also that given the existence of an inconsistency the one from mental 
patients is of a higher order. 
 
Figure 1: Diagram of redistribution between levels of the 3L and 5L (left) and identification of 
consistencies and inconsistencies (right). Source: Janssen et al. (2008) 
       
 
 
 
 
The dark cells represent inconsistent 
responses (size of inconsistency is given in 
cells) 
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Figure 2. Mean inconsistency weight by dimension and by group of illness. (*) Difference 
significant at p<.05 
 
 
Ordinality: Weak transitivity is satisfied in all dimensions for both subsamples (table 5). 
However the property of strict transitivity is not satisfied for the dimensions “mobility”, “usual 
activities” and “pain-discomfort” for mental care subsample. On the contrary, for the somatic 
subsample, all dimensions hold strong transitivity. 
It should be noticed that we are computing this property differently to how typically is 
done. The difference lays in the fact that we lack of dimension specific VAS and thus, our 
classification is done according to the general VAS. However, we argue that given our large 
data set and the relationship between VAS and each dimension score (see the property of 
validity results), the result should be similar for both methods. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
mo* sc ua* pd ad
Somatic 1 1 1 00.001 00.001
Mental 00.001 1 00.001 1,25 1,25
0
0,2
0,4
0,6
0,8
1
1,2
1,4
Somatic
Mental
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Table 5: Ordinality for each subsample 
   
SOMATIC MENTAL 
  3L VAS subgroup N 
VAS 
mean 
VAS 
p50 
5L 
mean 
5L 
p50 
WEAK STRONG N 
VAS 
mean 
VAS 
p50 
5L 
mean 
5L 
p50 
WEAK  STRONG 
M
O
B
IL
IT
Y
 
1 
Upper 98 85.82 85 1.08 1 
YES YES 
141 81.30 80 1.08 1 
YES YES 
Lower 112 62.65 65 1.16 1 160 45.73 50 1.09 1 
2 
Upper 66 78.41 78.5 2.42 2 
YES YES 
40 71.25 70 2.43 2 
YES NO Middle 118 63.69 65 2.57 2 33 50.55 50 2.39 2 
Lower 97 39.76 45 2.91 3 48 21.25 22.5 2.69 3 
3 
Upper 3 41.67 40 3.67 4 
YES YES 
1 5.00 5 1.00 1 
YES YES 
Lower 5 14.00 10 4.60 5 5 0.00 0 2.60 2 
S
E
L
F
-C
A
R
E
 
1 
Upper 155 83.09 80 1.03 1 
YES YES 
146 81.23 80 1.04 1 
YES YES 
Lower 162 59.59 62 1.14 1 174 46.53 50 1.06 1 
2 
Upper 43 74.12 71 2.19 2 
YES YES 
32 70.88 70 1.94 2 
YES YES Middle 59 60.68 60 2.36 2 35 44.86 45 2.20 2 
Lower 76 36.91 40 2.80 3 37 13.00 10 2.62 3 
3 
Upper 2 62.50 62.5 4.00 4 
YES YES 
1 50.00 50 4.00 4 
YES YES 
Lower 6 29.17 37.5 4.17 4 2 0.00 0 4.50 4.5 
U
S
U
A
L
 A
C
T
IV
IT
IE
S
 
1 
Upper 110 85.55 85 1.04 1 
YES YES 
1 4.00 4 1.01 1 
YES YES 
Lower 141 64.24 70 1.21 1 2 4.50 4.5 1.35 1 
2 
Upper 67 75.39 75 2.30 2 
YES YES 
50 73.42 70 2.30 2 
YES YES Middle 73 60.84 60 2.34 2 70 53.11 50 2.59 2 
Lower 88 41.98 45 2.75 3 63 27.40 30 2.73 3 
3 
Upper 11 47.27 40 4.45 5 
YES YES 
19 36.05 35 4.21 4 
YES NO 
Lower 11 13.27 10 4.45 5 20 6.00 5 3.95 4 
P
A
IN
 –
D
IS
C
O
M
F
O
R
T
 
1 
Upper 53 89.08 90 1.21 1 
YES YES 
82 85.71 85 1.07 1 
YES YES 
Lower 66 67.64 70 1.37 1 89 56.02 60 1.16 1 
2 
Upper 105 78.89 80 2.23 2 
YES YES 
53 79.15 75 2.32 2 
YES NO Middle 89 67.18 67 2.39 2 50 60.68 60 2.32 2 
Lower 150 48.16 50 2.69 3 105 37.53 40 2.64 3 
3 
Upper 17 65.24 65 3.81 4 
YES YES 
24 41.04 35 3.92 4 
YES YES 
Lower 23 27.17 25 4.22 4 24 5.63 5 4.25 4 
A
N
X
IE
T
Y
/D
E
P
R
E
S
S
IO
N
 
1 
Upper 93 86.05 85 1.12 1 
YES YES 
53 89.15 90 1.11 1 
YES YES 
Lower 117 59.32 60 1.21 1 70 61.80 65 1.29 1 
2 
Upper 69 78.57 79 2.22 2 
YES YES 
74 79.16 80 2.32 2 
YES YES Middle 100 65.40 65 2.33 2 54 60.91 60 2.65 3 
Lower 94 42.28 45 2.62 3 96 39.06 40 2.89 3 
3 
Upper 12 68.42 67 3.50 4 
YES YES 
35 49.00 50 4.09 4 
YES YES 
Lower 14 31.50 40 3.93 4 45 13.69 10 4.44 4 
 
The property of Ordinality –through the analysis of transitivity–measures an existing 
relationship between the VAS and the health dimensions that the EQ-5D-3L is unable to 
capture. It restricts the sign of this relationship. For example, transitivity on the 1-U, implies 
11 
 
that a change of VAS is accompanied by a change on the 5L (existence of relationship VAS, 
5L) of contrary sign (restriction on the relationship), i.e. a decrease on the VAS would imply an 
increase on the 5L.  
Thus, and with this thought in mind, it seems very suitable to compute the correlations 
on each dimension between the 5L punctuation and the VAS on each of the 3L’s levels, i.e. 
compute 
Corr(5L
j
,VAS|3L
j
=i) with i {1,2,3} and j {mo,…,ad} 
Performing such an analysis, it is found that all coefficients are negative on their values (table 
6). However, we can only reject the null hypothesis of independency (Corr(5L
j
,VAS|3L
j
=i)=0) 
at p<.1 on 10 out of 14 of coefficients for somatic patients and on 9 out of 15 for mental ones. 
Decreasing the threshold to p<.01 for somatic patients we can still reject the independency 
hypothesis for 7 out of the 14 coefficients, while on the mental care the rejection rate falls down 
to a third of the cases (5 out of 15).   
 
Table 6: Spearman’s rank correlation between VAS and 5L within 3L groups 
 
3L Somatic Mental 
  1 -0.12* -0.0562 
mo 2 -0.3058*** -0.1530* 
  3 -0.706* -0.4174 
  1 -0.2089*** -0.1029* 
sc 2 -0.3954*** -0.2923*** 
  3 -0.2906 -0.5000 
  1 -0.3306*** -0.3638*** 
ua 2 -0.0607 -0.2693*** 
  3 (.) -0.0321 
  1 -0.2249** -0.0566 
pd 2 -0.3478*** -0.3401*** 
  3 -0.4506*** -0.3072** 
  1 -0.0966 -0.1224 
ad 2 -0.275***  -0.3905*** 
  3 -0.1907 -0.2637** 
* Reject independency of distribution at p<.1   
** Reject independency of distribution at p<.05   
*** Reject independency of distribution at p<.01   
(.) Not enough observations to perform the analysis 
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Validity: The correlations between 3L and 5L scales are significant (p<.01) and strong 
(r>.7) for all dimensions and both subsamples (table 7). Moreover, this behavior within scales is 
stable among samples, and not significant change takes place when moving from one subsample 
to another.  
The correlations between the VAS and the dimensions are in all cases highly significant 
(p<.01) and of negative sign as was expected. While for the somatic sample passing from the 3L 
to the 5L generates an increase on the Spearman's rank correlation coefficient for all 
dimensions, on the mental care subsample this change diminishes the coefficient for mobility 
and self-care dimensions. Linking this with the points above, this could be an effect of the 
existence of more likely and of higher order inconsistencies on this group.  
Replicating the analysis but restricting to consistent responses only, it is found that the 
somatic sample remains quite impassive to this sample change, while the subgroup of mental 
patients changes significantly increasing on a notable way all coefficients regarding the 
relationship between 3L and 5L, and improving the relationship between the VAS and the 5L. 
This data screening is able to explain the decreases of “mobility” and “self-care” dimensions 
correlations with the VAS for the full sample of mental care patients when passing from 3L to 
5L. 
Table 7: Spearman’s rank correlation between VAS, 5L and 3L 
  
SOMATIC MENTAL 
  
3L,5L VAS,3L VAS,5L 3L,5L VAS,3L VAS,5L 
Fu
ll sam
p
les 
MO 0.835 -0.450 -0.490 0.811 -0.337 -0.282 
SC 0.883 -0.475 -0.518 0.821 -0.354 -0.345 
UA 0.841 -0.540 -0.563 0.816 -0.584 -0.605 
PD 0.726 -0.468 -0.529 0.845 -0.527 -0.548 
AD 0.822 -0.349 -0.389 0.845 -0.578 -0.618 
C
o
n
sisten
t 
R
esp
o
n
ses 
MO 0.872 -0.459 -0.494 0.918 -0.314 -0.324 
SC 0.924 -0.470 -0.516 0.944 -0.343 -0.372 
UA 0.894 -0.540 -0.583 0.915 -0.588 -0.637 
PD 0.759 -0.484 -0.526 0.912 -0.535 -0.565 
AD 0.866 -0.353 -0.381 0.885 -0.579 -0.624 
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Figure 3: Correlations between the 3L and 5L scales and the VAS, by subsample of patients 
using consistent responses 
 
 
We find that the higher differences with regard to the correlation between dimensions 
and the VAS are found on “mobility” -dimension in which somatic coefficient is much more 
correlated - and “anxiety/depression” –where we find a notable higher correlation for mental 
patients. These findings point out the existing heterogeneity on the weights given to each 
dimension when explaining the VAS and more particularly, how the type of illness affects these 
weights. Also important on this aspect is the fact that the change from 3L to the 5L version has 
not effect on attenuating this relationship between type of illness and correlation (VAS, 
Dimension) but, on the contrary, it seems to enhance it. 
As an auxiliary instrument to evaluate the property of Convergent Validity we calculate 
the Chronbach- α (table 8), finding that it is higher for the 5L scale (0.8175) than for the 3L 
scale (0.7789), meaning that there is a stronger dependence between the items in the EQ-5D-5L 
than in the 3L questionnaire. Once again, analyzing the Cronbach’s alpha for each group, 
differences arise. The scale reliability coefficient (Cronbach’s alpha) is for both questionnaires 
higher on the somatic subsample. Moreover, using the 5L increases the gap between these two 
subsamples, pointing out that the effect of the 5L instrument is deeper for somatic patients. This 
result comes at hand by the slight increase generated by the 5L-instrument on the mental sample 
with respect to the 3L instrument. 
 
 
 
-001
-001
-001
-001
-001
000
000
000
000
MO SC UA PD AD
Somatic (VAS, 3L) Mental (VAS,3L) Somatic (VAS,5L) Mental (VAS,5L)
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Table 8: Convergent Validity 
  
5L 3L 
Fu
ll 
Sam
p
le 
Average interitem covariance 0.495718 0.138048 
Number of items in the scale 5 5 
Scale reliability coefficient 0.8175 0.7789 
So
m
atic 
Average interitem covariance 0.503487 0.13088 
Number of items in the scale 5 5 
Scale reliability coefficient 0.8547 0.7936 
M
en
tal 
Average interitem covariance 0.50678 0.150926 
Number of items in the scale 5 5 
Scale reliability coefficient 0.8087 0.7898 
 
 
Discriminatory Power/Informativity: The number of health profiles without problems 
(11111) decreases from the 3L to the 5L for both subsamples as well as for the full sample, 
being this decrease statistically significant at p<.05 for all cases. Looking dimension by 
dimension, for the somatic sample it is found a highly significant (p<.01) reduction of “no 
problem” responses in all dimensions. In opposition, for the mental subsample it is found a 
significant reduction (p<.05) of “no problem” responses only for “usual activities” and 
“anxiety/depression”. 
Table 9: Proportion of “no problem” responses 
 
Full Sample Somatic Mental 
  3L 5L Change (%) 3L 5L Change (%) 3L 5L Change (%) 
11111 14.98 12.6 -15.89*** 14 12.4 -11.43** 16.1 12.84 -20.25*** 
Mo 55.3 52.29 -5.44*** 42.35 38.37 -9.4*** 70.07 68.47 -2.28 
Sc 68.82 67.26 -2.27* 63.24 59.61 -5.74*** 75.23 76.13 1.20 
Ua 48.99 44.99 -8.16*** 50.3 45.83 -8.89*** 47.5 44.02 -7.33** 
Pd 31.36 27.9 -11.03*** 23.47 18.48 -21.26*** 40.45 38.83 -4.00 
Ad 35.74 31.17 -12.79*** 42.15 37.04 -12.12*** 28.41 24.38 -14.19*** 
 
* Difference between 3L and 5L significant at p<.1 
  
 
** Difference between 3L and 5L significant at p<.05 
   
 
*** Difference between 3L and 5L significant at p<.01 
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Table 10: Informativity through Shannon Index (H’) and Shannon Eveness Index (J’) 
  
5L 3L 
Change     H' MaxH' J' H' MaxH' J' 
SOMATIC 
mo 1.89 2.32 0.81 1.09 1.58 0.69 15.30% 
sc 1.55 2.32 0.67 1.04 1.58 0.66 1.14% 
ua 1.84 2.32 0.79 1.21 1.58 0.77 2.97% 
pd 1.90 2.32 0.82 1.15 1.58 0.73 10.80% 
ad 1.80 2.32 0.78 1.23 1.58 0.78 -0.34% 
MENTAL 
mo 1.37 2.32 0.59 0.96 1.58 0.61 -3.00% 
sc 1.13 2.32 0.49 0.85 1.58 0.54 -10.83% 
ua 1.98 2.32 0.85 1.35 1.58 0.86 -0.48% 
pd 2.01 2.32 0.87 1.38 1.58 0.88 -1.15% 
ad 2.21 2.32 0.95 1.45 1.58 0.92 3.41% 
 
We observe that for the subsample of patients with somatic illnesses the level of 
informativity increases by using the 5L scale in four of the five dimensions. However, for those 
patients with mental diseases, we observe the opposite: informativity decreases in four of the 
five dimensions, observing an increase in informativity only for anxiety/depression. Although 
we can think this is not a good result, we cannot ignore the correlations between the dimensions 
and the VAS, as long as loses on informativity take place on these dimensions with lower 
correlation. This relationship tells us that, in fact, the 5L-version is able to increase the 
informativity of the EQ-5D on the relevant patient-specific dimensions. This asymmetry on the 
informativity variation over dimensions was expected given our sample and the methodology to 
compute this measure. Scores on dimensions not related to the illness of the respondent 
(mobility for mental care patients, for example) tend to be concentrated on low values and thus, 
the extra levels for high punctuations will remain unused, reducing the value of J’. 
However, we find this method to compute the information gain/loss by switching from 
the 3L to the 5L quite theoretical. From a more practical point of view, we argue that the scale 
more valuable in terms of informativity is the one that can split the sample into the highest 
number of “meaningful” groups. Obviously, the 3L-instrument split the sample into three 
groups on each dimension (3L-1, 3L-2 and 3L-3) while the 5L-instrument do it into five (5L-1, 
5L-2, 5L-3, 5L-4 and 5L-5), but the question we pose here is: Do these groups have a meaning 
by themselves?. Each of these subgroups would allow us to assign statistically a particular rank 
of the VAS to each individual belonging to it (the p-confidence interval of the mean). However, 
it may well be the case that this rank for two groups is overlapped. In such a case, one can argue 
that these two groups are not separable and thus they should merge into one. From a 
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mathematical point of view what we are looking is for the existence of an injective 
correspondence such that 
 
with  for the 3L version and for the 5L. For example computing the 
mean in mobility for the 5L-2 on the mental care sample, we get that its 95% confidence 
interval is equal to (46.13402, 56.5882) i.e. c(2)= (46.13402, 56.5882) but then, computing c(3) 
we find that c(3)=(40.45239, 55.54761). Since , level 3 doesn’t really 
discriminate on regard the VAS with respect to level 2 and thus it doesn’t add information to the 
data set. 
Making use of this reasoning, we suggest the use of the following index for each 
dimension: 
 
where k denote the dimension analyzed. This index is just the number of not overlapping groups 
(numerator) over the maximum number of not-overlapping groups (denominator). 
Consequently, the index reflects the proportion of useful or meaningful groups. We will call it 
Effective usefulness. This index has an upper bound of one, and would correspond to the 
existence of an injective correspondence from the levels of the dimension to the VAS. In this 
case all levels would be perfectly distinguishable between them in terms of VAS and thus all 
levels contain unique information. The minimum score would be zero, and corresponds to the 
case in which all confidence intervals overlap between them and thus the scale itself provides 
zero information. 
However,  it is easy to seethat the gain on informativity from increasing the number of 
levels may depend on the actual number of levels
2
. Therefore we assume this relationship to be 
concave reflecting the fact that the potential gain on informativity is decreasing on the number 
of levels
3
. For this purpose, we modify the above formula to compute an Absolute index ( ) 
on the following way: 
) 
where  just represents the number of levels of the scale (Max{L}=5 or Max{L}=3 
depending on the instrument). This absolute index accounts for the potential informativity of the 
scale ( )) weighted by the effective usefulness of it ( ). Notice that this index has as 
                                               
2
 Notice that a comparison based only on would imply that having just one group is as informative as having 100 
meaningful groups. 
3 This assumption just implies that the most important splits are the first ones as they generate a clear and powerful 
discrimination. As illustration, consider a dataset. Clearly the first (meaningful) split i.e. from passing from one group 
to two, is more important to a new split that generates 1001 groups instead of 1000. 
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lower bound of zero, which is attained when the effective usefulness of the scale is zero or on 
the trivial case in which there is just one level.  
In order to aggregate this information into an Overall index ( ) reflecting the 
informativity of the scale among all dimensions, we add all the  indexes, weighted by the 
respective correlations between the dimensions and the VAS (in absolute value), i.e. 
 
Looking at the results for our dataset (table 11), we see that the overall index of 
informativity (OI) increases in both, mental and somatic groups, when we change the 3L 
version for the 5L. Looking closer, it is found that for somatic patients all dimensions gain in 
informativity changing from 3L to 5L. Moreover, results are consistent with the ones provided 
by the Shannon Evenness Index (more by coincidence than by construction), with “mobility” 
and “pain/discomfort” as the principal benefited dimensions, followed by “usual activities” and 
“self-care”. The less benefited found is in this case “anxiety depression”.  
Although the ranking for dimensions on regards to informativity is the same as the one 
provided by the Shannon Evenness index, the magnitude is critically different. Especially 
striking is the change on “anxiety/depression”, dimension for which the Shannon Evenness 
index accounts for a loss while our absolute index for a gain. In our case, the gain is explained 
by the fact that the increase on the potential informativity of the scale is not completely 
counteracted by the decrease of the effective usefulness ( ). Although this decrease is quite 
important, conceptually we can understand that we can construct three groups that discriminate 
correctly: 5L-1,5L-2 and 5L-[3,4,5], where this last subgroup comes from the merge of the three 
overlapping groups. Thus we can say up to here that we have three effective subgroups on this 
5L scale. However, we also have the extra information that 5L-1 and 5L-2 discriminate 
effectively versus 5L-3, 5L-4 and 5L-5 so in fact we have more information that the one that 
follows from the existence of three groups. Therefore, the information we get from the 
introduction of the new levels is -although of small magnitude- positive. The result for the rest 
of dimensions is easily explained by looking the tables. On self-care we get that only 5L-5 is 
problematic and thus effective usefulness of the scale does not seem very affected. Similar 
argument can be used to explain the result on the “usual activities” dimension. 
Regarding mental care patients, things become harder to interpret. First thing we should 
notice is that this new indicator of informativity provides results completely different to the 
ones of the Shannon Evenness index. All dimensions gain on informativity except the one of 
mobility. The decrease on this dimension is clear when examining the table: From getting three 
groups completely meaningful on the 3L version, we get none on the 5L. This dramatic change 
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is caused by the extreme behavior of 5L-5, that avoids the existence of any injective 
relationship, i.e. the mean VAS of the 5L-5 cannot be distinguished from any other group. To 
this, we should also add that the mean behavior of the VAS on the 5L-2 and 5L-3 cannot either 
be distinguished. This dramatic change on the effective usefulness of the 5L scale, push down 
the Absolute index up to get a negative change. The case of self-care dimension, is similar in 
essence to the case of anxiety depression for somatic patients except for the fact that the 3L 
scale on this case is not injective (it fails for 3L-2 and 3L-3) and thus the change on the effective 
usefulness index  when passing from the 3L to the 5L is of lower magnitude. On usual activities 
and pain discomfort, only the pairs 5L-4 and 5L-5 fail to be distinguishable and for the anxiety 
depression dimension, the relationship between 5L and VAS remain completely injective 
attaining in both 3L and 5L the maximum absolute index. 
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Table 11: Informativity through Effective Index ( ), Absolute Index ( ) and Overall Index (OI) 
Somatic 
 
mo sc ua pd Ad OI mo sc Ua pd ad OI 
1 73.63 71.66 73.76 79.11 71.65   73.46 71.08 73.58 77.18 71.16   
2 65.37 60 63.38 67.47 64.92   58.89 53.77 57.83 62.46 60.59   
3 56.27 49.58 53.85 57.37 55.46   24.37 37.5 30.27 43.35 48.54   
4 45.77 37.21 38.48 47.93 45.67     
    
  
5 12.5 30 34 24 44.17     
    
  
Overlap 
0 2 1 0 3   0 0 0 0 0   
 (3,5)(4,5) (4,5)  (3,4)(3,5)(4,5)         
Not Over 10 8 9 10 7   3 3 3 3 3   
 1 0.80 0.9 1 0.7 
3.56 
1 1.00 1 1 1 
2.49  
1.61 1.29 1.45 1.61 1.13 1.10 1.10 1.10 1.10 1.10 
Correlation 
with VAS 
-0.4918 -0.5199 -0.562 -0.527 -0.392 -0.449 -0.471 -0.5367 -0.467 -0.345 
 
Mental 
 
mo sc Ua pd Ad OI mo sc ua pd ad OI  
1 61.33 61.71 71.51 70.08 74.09   62.40 62.36 70.26 70.26 73.59   
2 51.36 48.28 54.02 60.03 65.72   45.77 41.53 49.81 53.70 57.58   
3 48.00 35.00 45.01 47.91 52.90   0.83 16.67 20.64 23.33 29.14   
4 17.69 26.36 28.56 28.64 37.00     
    
  
5 51.25 2.50 27.84 19.15 22.48     
    
  
Overlap 
5 4 1 1 0   0 1 0 0 0   
(2,3)(1,5)(
2,5)(3,5)(
4,5) 
(2,3)(3,4)
(3,5)(4,5) 
(4,5) (4,5)    (2,3)     
Not Over 5 6 9 9 10   3 2 3 3 3   
 0.5 0.60 0.9 0.9 1 
3.23 
1 0.67 1 1 1 
2.48  
0.80 0.97 1.45 1.45 1.61 1.10 0.73 1.10 1.10 1.10 
Correlation 
with VAS 
-0.2861 -0.3458 -0.603 -0.552 -0.617 -0.336 -0.354 -0.5804 -0.527 -0.577 
 
 
Change Somatic Change Mental 
 
mo sc ua pd ad OI  mo sc ua pd ad OI 
 0,0% -20,0% -10,0% 0,0% -30,0%   -50,0% -10,0% -10,0% -10,0% 0,0%   
 46,5% 17,2% 31,8% 46,5% 2,5%   -26,8% 31,8% 31,8% 31,8% 46,5%   
OI           43,1%           30,3% 
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Face Validity: We analyze here the opinion reported by patients concerning the 
capacity of both questionnaires to reflect individuals’ health status. A first look at the data gives 
us the following result: the proportion of individuals who report to prefer the 5L questionnaire 
(24.7%) is significantly different (p<.01) than the proportion of individuals preferring the 3L 
questionnaire (18%). However the majority of respondents are indifferent between both 
questionnaires.  
Table 12: Face validity by subsamples of patients 
 
Somatic Mental 
 
% Std. Err. % Std. Err. 
5L *** 28.48% 0.020307 20.43% 0.019673 
3L ** 15.15% 0.016132 21.38% 0.020005 
Indifferent 48.89% 0.022491 50.36% 0.024397 
N/A 7.47% 0.011832 7.84% 0.013115 
        * Difference between samples significant at p<.1 
        ** Difference between samples significant at p<.05 
        *** Difference between samples significant at p<.01 
 
Performing separate analysis for somatic and mental patients (table 12), we observe that 
for somatic patients we find a higher support for 5L than for the 3L (p<.01) but when looking 
the mental care subsample this relationship is no longer significant. Consequently with these 
findings, we also get that somatic patients are more likely to express their preference toward the 
5L and less likely toward 3L than mental ones (p<.01 and p<.05 respectively). 
Another interesting result is found when we look at preferences for 3L and 5L 
questionnaires distinguishing by the self-perception of the patient of his illness’ severity (table 
13). Examining somatic patients, it is found that those patients with severe illness’ perception 
tend to report their preference towards the 5L significantly more frequently than those with 
intermediate perception (p<.05) that, at the same time, report it more frequently than those with 
mild perception (p<.05).  
Doing the same exercise for mental care patients, not effect of self-perception of the 
illness on this regard it is found. Only the proportion of indifferent responses presents a 
marginal statistically significant effect (p<.1) when comparing those reporting a mild perception 
with those reporting a severe one. 
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Table 13: Face validity by subsamples of patients 
  
Somatic Mental 
  
% Std. Err. % Std. Err. 
Mild * 
5L 16.13% 0.038346 16.49% 0.037879 
3L 11.83% 0.033669 20.62% 0.041291 
Indifferent 56.99% 0.051617 57.73% 0.050417 
N/A ** 15.05% 0.037282 5.15% 0.022567 
Intermediate 
5L 28.35% 0.028334 22.34% 0.03046 
3L 17.72% 0.024004 20.21% 0.029367 
Indifferent 47.64% 0.0314 50.53% 0.036562 
N/A 6.30% 0.015274 6.91% 0.018553 
Severe *** 
5L *** 39.37% 0.043525 21.19% 0.037778 
3L ** 14.17% 0.031071 24.58% 0.039803 
Indifferent 40.94% 0.043807 44.92% 0.045985 
N/A 5.51% 0.020331 9.32% 0.026879 
 
* Difference between samples significant at p<.1 
 
** Difference between samples significant at p<.05 
 
*** Difference between samples significant at p<.01 
Closing this point, we can compare the patterns of both subsamples within a severity 
reported level by performing a simultaneous test of multiple constraints. This test will shed light 
about whether we can reject that somatic and mental care patients’ data are dropped from the 
same distribution. This exercise tell us that distributions differ marginally on the mild level 
(p<.1)
4
 and on a very strong way on the severe level (p<.01).  
The last point to be considered is the effect of being inconsistent on the perceived 
usefulness of the survey mode (Figure 4). Analyzing this factor as a potential determinant of 
preference for one or another survey, we found that the proportion of patients who strictly prefer 
the 5L to the 3L survey is significantly higher among consistent than for inconsistent ones 
(p<.05). Similarly, we can say that this relationship is reversed when analyzed the strict 
preference between 3L and 5L survey (p<.01). Performing a simultaneous test of multiple 
constraints, we can reject that both distributions are equal (p<.05) pointing out the importance 
for the patient of being or not consistent when evaluating the usefulness of the survey. Withal, 
and once again, we have to talk about differences when evaluating its effect on the somatic or 
mental care group of patients. While for the former group, the results of the whole subsample 
can be extrapolated, for the second one, we cannot reject the hypothesis of equal distribution 
with respect to being consistent/inconsistent. More important still is the fact that the distribution 
of somatic-inconsistent patients and the one of mental-inconsistent ones look so similar that we 
                                               
4
 This result however seems to be more an accident than a fact, since on the somatic subsample there is 
an unusual high proportion of “not applicable” responses.  
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cannot reject that these are the same, i.e. we can assume that their distribution of responses are 
the same. On the other hand, we can reject the equality of distributions (p<.01) when we look 
only at consistent patients. 
 
Figure 4: Face validity results, considering inconsistencies 
 
 
3.3 Other results 
 
We can see that there is a significant difference between somatic and mental patients in 
how they value their health in the VAS. There is a positive difference of 7.6 points, in mean, in 
favor of somatic patients. A t-test assuming unequal variances for the two subsamples returns us 
a t-statistic of 5.2668 (Satterthwaite's degrees of freedom equals 784.791), rejecting the null 
hypothesis (p<.01) of equality on means and accepting that somatic patients tend to report 
higher VAS than mental ones do.  
However, this can be due to differences in the sample composition. Apart from the 
observed differences on the descriptive data between mental and somatic patients on regard to 
gender composition (“gender”), level of education (“studies”) and the main economic activity 
(“activity”) we have an extra source of imbalance between our two samples: The institution 
(primary, specialist and day care hospital) in which the survey has been delivered. 
Table 14: Distribution of patients attending to the institution where the questionnaire was 
delivered 
 
Primary Specialist Day Care Total 
Somatic 326 190 0 516 
Mental 3 284 157 444 
Total 329 474 157 960 
 
These features could be responsible for a problem of omitted variable biasing the above 
analysis, since if a correlation between a variable and the VAS exists, the above difference may 
0%
20%
40%
60%
5L 3L Indifferent N/A
Somatic Consistent
Somatic Inconsistent
Mental Consistent
Mental Inconsistent
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be explained not by being a mental or somatic patient but by a correlation between this 
classification with the variable really relevant. 
Performing an ANCOVA (table 15) introducing all the relevant information to shed 
light over this issue, we find that there is not direct link between mental/somatic classification 
and the VAS. Moreover, performing the same analysis but excluding the variable “institution” it 
is found that the variable mental is highly significant (p<.01) providing evidences that what has 
carried out the difference between mental and somatic VAS’s score is its imbalanced on regard 
the institution in which patients are being treated. Looking the coefficients of the variable 
“institution”, it is found that patients being attended on the mental care centre and by the 
specialist, score significantly lower (p<.01) than those attended on a primary health care centre, 
being the rest of variables equal. Moreover, can also be checked that patients from the day care 
hospital penalize their VAS more than those coming from the specialist (p<.01). 
Table 15: ANCOVA using the VAS as response variable 
  Partial SS Df MS F Prob>F 
Model 206,747.99 34 6,080.82 27.36 0 
Mobility 287.69 4 71.92 0.32 0.8623 
Self-Care 1,609.83 4 402.46 1.81 0.1248 
Usual Activities 11,408.81 4 2,852.20 12.83 0 
Pain Discomfort 7,715.32 4 1,928.83 8.68 0 
Anxiety/Depression 14,557.92 4 3,639.48 16.37 0 
Gender 22.99 1 22.99 0.1 0.7479 
Studies 1,881.32 3 627.11 2.82 0.038 
Activity 1,550.55 5 310.11 1.4 0.2238 
Severity 1,145.72 2 572.86 2.58 0.0766 
Institution 3,948.45 2 1,974.22 8.88 0.0002 
Mental 3.99 1 3.99 0.02 0.8935 
Residual 180,943.76 814 222.29      
Total 387,691.75 848 457.18    
 
 
4. Conclusion and final remarks 
This paper analyzes the psychometric properties of the new EQ-5D-5L questionnaire 
through a parallel testing of the standard 3L and 5L versions of the EQ-5D instrument in two 
well established populations of chronic patients (mental/somatic).  
Results show that, for both populations of chronic patients analyzed, the new EQ-5D-5L 
is sensitive to the introduction of two intermediate severity levels. Although this assertion is 
also true for each of the subsamples, the strength of the sensitiveness is mixed. 
In all dimensions, it seems that somatic patients take more advantage of the extra levels 
introduced by the EQ-5D-5L. This group, in comparison with the mental one, reduces to a 
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greater extent the missing response rate, commit less (and of lower importance) inconsistencies, 
get a higher correlation of the 5L scale and the VAS within the 3L levels, complement better the 
dimensions to get an overall score (measured through the Cronbach’s alpha), reduce in a more 
significant way the “no problem” response and the informativity gain is also superior (for both 
the Shannon Eveness Index and our Absolute Index). 
This higher performance of the EQ-5D-5L on somatic patients is endorsed by a higher 
preference of somatic patients toward the 5L version of the questionnaire than to the 3L one. A 
critical factor affecting this preference toward one or another version of the EQ-5D is whether 
the patient is consistent or inconsistent. Results show that mental patients do more and higher 
inconsistencies. In addition, this feature seems to be supported by previous research on the 
topic. Comparing our result with the ones of Janssen et al. (2012) and Kim et al. (2012), we find 
a higher proportion of inconsistent responses (3.8% versus 2.9% and 3.5% respectively). 
However, excluding mental patients from the analysis the proportion of inconsistent responses 
decreases to 2.9%, exactly the same found by Janssen et al. (2012).  
Looking to the weights of inconsistencies (table 16) we get mixed effects replicating 
somatic patients better the results of Kim et al. (2012) and mental ones slightly better in Janssen 
et al.’s ones. However, we should be aware that this last result is explained by the huge 
difference existing on the dimension usual activities; while for the remaining four dimensions 
somatic patients minimize differences. Withal, when looking at this result we should remember 
that the dataset of Janssen et al. makes use of a non-negligible sample of mental patients (18% 
of the total), which according to the results presented above, may increase the average 
inconsistency. This point seems strengthened by noticing that at each dimension (excluding self-
care) the dataset with lower average inconsistence is our somatic one or Kim et al.’s one 
(composed by cancer patients) followed by Janssen et al.’s and, finally, with the higher average 
inconsistency weight, our mental sample. Looking the average inconsistency weight for the full 
samples, we can notice a trend increasing on the mental care patients proportion used to 
generate the sample.  
Table 16: Inter-research comparison of mean inconsistency weights 
  Somatic Mental Kim (2012) Janssen (2012) 
Mo 1.00 1.32 1.09 1.146 
Sc 1.00 1.00 1.21 1.186 
Ua 1.00 1.29 1.08 1.197 
Pd 1.08 1.25 1.06 1.131 
Ad 1.16 1.25 1.14 1.185 
Average Inconsistency 
Weight 
1.05 1.222 1.12 1.17 
Distance w.r.t. Kim 0.24 0.43     
Distance w.r.t. Janssen 0.31 0.30     
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Therefore, our results, as well as this basic comparison with similar studies seem to 
confirm that mental patients commit more and higher inconsistencies.  
This point, together with our finding suggesting that inconsistent patients tend to 
underestimate the utility of the 5L version, open the debate of whether the introduction of 
intermediate levels is really helping patients with mental illnesses or, on the contrary, is 
introducing an extra difficulty that is not corresponded with a gain on the quality of the data 
collected. 
This research should be taken as a caveat about the importance of other factors different 
from the mere 3L and 5L states when evaluating the convenience and suitability of the different 
versions of the EQ-5D. On this paper we have analyzed the somatic/mental illness 
classification, but may be other relevant classificatory variables affecting the impact of moving 
from the 3L to the 5L. While our results show the suitability of the 5L version in both 
subsamples, they also show that it is much more suitable and effective for somatic patients. 
These subsamples’ differences may be a concern when aggregating and comparing different 
data. While an aggregation will provide us with a general and wide picture of the effects, it 
would also provide us non-realistic results as long as these results are an average of well 
distinguishable groups that may have different reactions to the introduction of the two 
intermediate levels. 
We have also made an effort in suggesting new ways to measure the effects of the 
introduction of intermediate levels, understanding that there are several complementary ways to 
measure it but also that the tools developed up to now may be insufficient to cover all the 
relevant aspects that should be analyzed on this particular context. This should not be read as a 
critic but as an encouragement to introduce new methodologies and properties in future 
researches that may shed light over the topic at hand.  
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